从“血水同治”论治甲状腺相关性眼病  

Treatment of thyroid-associated ophthalmopathy from“treating both blood and water”

作　　者：邓奕 谢灿明 李方芳 黄群 姚小磊[1,2] DENG Yi;XIE Canming;LI Fangfang;HUANG Qun;YAO Xiaolei(The First Hospital of Hunan University of Chinese Medicine,Changsha 410007,China)

机构地区：[1]湖南中医药大学第一附属医院,湖南长沙410007 [2]湖南中医药大学,湖南长沙410208

出　　处：《陕西中医》2024年第12期1666-1669,共4页Shaanxi Journal of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目(82174443);湖南省中医药防治眼耳鼻咽喉疾病与视功能保护工程技术研究中心项目(2018TP2008);学科建设“揭榜挂帅”项目(22JBZ029);中医药防治眼耳鼻咽喉疾病湖南省重点实验室项目(2017TP1018)。

摘　　要：甲状腺相关性眼病(TAO)是一种自身免疫性疾病,中医学将其归入“鹘眼凝睛”范畴,认为其发生与痰湿阻滞、血脉瘀滞密切相关。活血利水法是彭清华教授治疗眼底疾病的常用治法,笔者发现其法在治疗眼眶疾病上同样疗效甚佳。血水在生理上同源,在病理上共病,其病理产物痰湿与血瘀恰与TAO的致病因素相拟合。故基于“血水同治”理论,分阶段探讨眼病“痰瘀互结”的病机特点,并提出“调理气机”对治疗痰瘀互结型TAO的重要性,为其辨证论治提供新思路、新方向。Thyroid-associated ophthalmopathy(TAO)is an autoimmune disease,which is classified as“eye-catching”in traditional Chinese medicine,and it is considered that its occurrence is closely related to phlegm-dampness block and blood stasis.Ophthalmology method of promoting blood circulation and promoting diuresis is a commonly used treatment for fundus diseases by professor Peng Qinghua.The author found that it is equally effective in treating orbital diseases.Blood and water are physiologically homologous and pathologically co-morbid,and its pathological products,phlegm-dampness and blood stasis,are just consistent with the pathogenic factors of TAO.Therefore,based on the theory of“treating both blood and water”,this paper discusses the pathogenesis characteristics of“phlegm and blood stasis”of eye diseases in stages,and puts forward the importance of“regulating Qi-flow”in treating TAO,providing new ideas and new directions for its syndrome differentiation and treatment.

关 键 词：甲状腺相关性眼病 GRAVES病 血水同治 血水互结 痰瘀互结 活血利水法 

分 类 号：R581[医药卫生—内分泌]